MBX today
$54.51-$3.21 (-5.56%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourLeaning Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minBearish
Daily trend turns up above $56.20
Key levels
Resistance$65.00
Resistance$57.42
Support$52.32
Support$47.55
Latest news & SEC filings
AnalystHC Wainwright starts MBX Biosciences coverage with Buy rating
SEC FilingMBX Biosciences, Inc. filed an insider trading report (Form 4)
AnalystHC Wainwright starts MBX Biosciences coverage with Buy rating and $90 price target
EarningsMBX Biosciences posts Q3 2026 results
All MBX news →About MBX Biosciences
MBX Biosciences is a drug developer in the clinical testing phase, creating peptide-based treatments for hormone and metabolism conditions. Its main candidates target chronic low blood calcium after parathyroid problems, obesity, and low blood sugar following weight-loss surgery. The company uses its own peptide engineering technology and is based in the United States.
Based on the company's 10-K filed Mar 12, 2026.
Nasdaq · Healthcare
MBX Biosciences, Inc. (MBX)
What Is the Price Target for MBX?
SEPT Low Target
$70.00
SEPT Mid Target
$88.00
SEPT High Target
$150.00
Analyst Consensus
$88.00
Is MBX a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for MBX.
Start Free Trial →Is MBX Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B, Analyst Consensus
Fair Value
$71.48
12
Moat Score
NONE
3/9
Piotroski Score
73.9
Altman Z-Score
What Is Smart Money Doing with MBX?
Insider Signal
NEUTRAL
1 buys / 3 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Hoerter Steven L. | director officer | Sale | 4,893 | $268K | Nov 10, 2026 |
| Azoulay Salomon | officer | Sale | 373 | $20K | Nov 4, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →MBX Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
59.11%
FCF Growth YoY
-47.4%
Revenue Trend
UNKNOWN
Dark Pool Trades for MBX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for MBX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:40 | $54.51 | 1,366 | $$74K | SELL |
| 19:17:32 | $55.02 | 1,784 | $$98K | MIDPOINT |
| 18:55:59 | $54.95 | 1,546 | $$85K | SELL |
| 18:51:42 | $54.95 | 1,050 | $$58K | MIDPOINT |
| 17:06:04 | $56.55 | 1,050 | $$59K | BUY |
5 dark pool trades shown · $$375K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for MBX
PREVIEWSEPT Investing provides real-time options flow tracking for MBX, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $60 | Dec 18 | 36 | $$2840 | 4 | SWEEP |
| CALL | $60 | Dec 18 | 36 | $$1420 | 2 | SWEEP |
| CALL | $60 | Dec 18 | 36 | $$1420 | 2 | SWEEP |
| CALL | $60 | Dec 18 | 36 | $$1420 | 2 | SWEEP |
| CALL | $60 | Dec 18 | 36 | $$1420 | 2 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for MBX Biosciences, Inc. (MBX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →MBX — frequently asked questions
What is MBX stock price today?
MBX Biosciences, Inc. (MBX) is at $54.51, down 5.56% (-$3.21) at the Nov 12, 2026 close.
Why is MBX stock moving today?
Latest MBX news — Nov 12, 2026: HC Wainwright starts MBX Biosciences coverage with Buy rating · Nov 12, 2026: MBX Biosciences, Inc. filed an insider trading report (Form 4)
What is the MBX price target?
The average analyst price target for MBX is $88.00, ranging from $70 to $150, based on 8 analysts. Latest: Stifel maintains on Oct 12, 2026.
What do analysts rate MBX?
Analyst ratings for MBX: 0 Buy, 8 Hold, 0 Sell — consensus Hold.
Did MBX beat earnings?
MBX last reported on Aug 6, 2026: EPS -$0.78 vs -$0.63 expected — a miss of 23.3%.
Does MBX pay a dividend?
MBX does not currently pay a dividend.
What are MBX support and resistance levels?
Support: $52.32, $47.55, $38.24. Resistance: $57.42, $65.00, $70.00.
What are insiders doing with MBX?
Insider activity: NEUTRAL, 1 buys and 3 sells in the last 90 days.
What is the latest news on MBX?
Nov 12, 2026: HC Wainwright starts MBX Biosciences coverage with Buy rating · Nov 12, 2026: MBX Biosciences, Inc. filed an insider trading report (Form 4) · Nov 12, 2026: HC Wainwright starts MBX Biosciences coverage with Buy rating and $90 price target